The treatment of distant metastases in soft tissue sarcoma

Seminars in Radiation Oncology

Volumn 9, Issue 4, 1999, Pages 389-400

  Sawyer, M ^a   Bramwell, V ^a  

^a LONDON REGIONAL CANCER PROGRAM   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; EPIRUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; MESNA; MILODISTIM; MITOMYCIN C; NAVELBINE; RAZOXANE; TOPOTECAN; VINCRISTINE;

ALOPECIA; BONE MARROW SUPPRESSION; BONE MARROW TOXICITY; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER METASTASIS; LUNG METASTASIS; META ANALYSIS; METASTASIS; NAUSEA; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE; RETROPERITONEAL SARCOMA; REVIEW; SOFT TISSUE SARCOMA; TREATMENT OUTCOME; VOMITING;

EID: 0032860150     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-4296(99)80033-2     Document Type: Article

References (73)

1. Yang JC Glatstein EJ Rosenberg SA Sarcomas of soft tissues DeVita VT Jr Hellman S Rosenberg S Cancer: Principles and Practice of Oncology ed 4 1993 JB Lippincott Philadelphia, PA 1436 1488
2. Suit HD Patterns of failure after treatment of sarcoma of soft tissue by radical or by conservative surgery and radiation Cancer Treat Symp 2 1983 241 246
3. Lawrence W Jr Donegan WL Nachimuth N Adult soft tissue sarcomas: A Pattern of Care. Survey of the American College of Surgeons Ann Surg 205 1987 349 359
4. Presant CA Russell WO Alexander RW Soft-tissue and bone sarcoma histopathology peer review: The frequency of disagreement in diagnosis and the need for second pathology. opinions. The Southeastern Cancer Study Group experience J Clin Oncol 4 1986 1658 1661
5. Rosen G Forscher C Lowenbraun S Synovial sarcoma: uniform response of metastases to high dose ifosfamide Cancer 73 1994 2506 2511
6. Van Glabbeke M van Oosterom AT Nielsen OS Prognostic factors for first line high dose chemotherapy outcome in advanced soft tissue (STS): An overview of 759 patients (PTS) included in studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) J Clin Oncol 17 1999 150 157
7. Unpublished data Bramwell V Anderson D Cancer Care Ontario Practice Guidelines Initiative EBR#11.1: Doxorubicin-based combination chemotherapy for palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma 1999
8. Mouridsen HT Bastholt L Somers R Adriamycin versus epirubicin in advanced soft tissue sarcomas: A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma Group Eur J Cancer Clin Oncol 25 1987 1477 1483
9. Nielsen OS Dombernowsky P Mouridsen H High dose epirubicin is not an alternative to standard dose doxorubicin in the treatment of advanced soft tissue sarcomas: A study of the EORTC Soft Tissue and Bone Sarcoma Group Br J Cancer 78 1998 2634 2639
10. Casper ES Gaynor JJ Hajdu SI A prospective randomized trial of adjuvant chemotherapy with bolus versus continuous infusion of doxorubicin in patients with high grade soft tissue sarcoma and an analysis of prognostic factors Cancer 68 1991 1221 1229
11. Wexler LH Ameliorating anthracycline cardiotoxicity in children with cancer: Clinical trials with dexrazoxane Semin Oncol 10 1998 86 92
12. Lopez M Vici P Di Lauro L Randomized prospective clinical trial of high-dose epirubicin and dexrazoxane in patients with advanced breast cancer and soft tissue sarcomas J Clin Oncol 16 1998 86 92
13. Mayer LD Tai LC Ko DS Influence of vesicle size, lipid composition, and drug to lipid ratio on the biological activity of liposomal doxorubicin in mice Cancer Res 49 1989 5922 5930
14. Rahman A Fumagalli A Barbieri B Antitumor and toxicity evaluation of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes Cancer Chemother Pharmacol 16 1986 22 27
15. Gabizon A Dagan A Goren D Liposomes as in vivo carriers of adriamycin: Reduced cardiac uptake and preserved antitumor activity in mice Cancer Res 42 1982 4134 4739
16. Herman EH Rahman A Ferrans VJ Prevention of chronic doxorubicin cardiotoxicity in beagles by liposomal encapsulation Cancer Res 43 1983 5427 5432
17. Casper ES Schwartz GK Sugarman A Phase I trial of dose intense liposome encapsulated doxorubicin in patients with advanced sarcoma J Clin Oncol 15 1997 2111 2117
18. Skubitz KM Early results of pegylated liposomal doxorubicin (Doxil) in refractory sarcoma Proc Am Soc Clin Oncol 17 1998 524a
19. Garcia AA Kempf R Rogers M A phase II study of doxil (liposomal doxorubicin): Lack of activity in poor-prognosis adult soft tissue sarcoma Ann Oncol 9 1998 1131 1133
20. (abstr) Elson P Chidiac Budd GT Phase II trial of doxil in advanced soft tissue sarcomas Proc Am Soc Clin Oncol 17 1998 513a
21. Demetri GD Elias AD Results of single agent and combination chemotherapy for advanced soft tissue sarcomas Hematol Oncol Clin North Am 9 1995 765 785
22. Bramwell VHC Mouridsen HT Santoro A Cyclophosphamide versus ifosfamide: Final report of a randomized phase II trial in adult soft tissue sarcomas Eur J Cancer 23 1987 311 321
23. Elias AD Eder JP Shea T High-dose ifosfamide with mesna uroprotection: A phase I study J Clin Oncol 8 1990 170 178
24. Le Cesne A Antoine E Spielmann T High-dose ifosfamide: Circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas J Clin Oncol 13 1995 1600 1608
25. Buesa JM Lopez-Pousa A Martin J Phase II trial of first-line high dose ifosfamide in advanced soft tissue sarcomas of the adult: A study of the Spanish Group for Research on Sarcomas (GEIS) Ann Oncol 9 1998 871 876
26. (abstr) van Oosterom AT Krzemienlecki K Nielsen OS Randomized phase II study of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) comparing two different ifosfamide (IF) regimens in chemotherapy untreated advanced soft tissue sarcoma (STS) patient (pts) Proc Am Soc Clin Oncol 16 1997 496a
27. Patel SR Vadhan-Raj S Papadopolous N High-dose ifosfamide in bone and soft tissue sarcomas: Results of phase II and pilot studies dose response and schedule dependence J Clin Oncol 15 1997 2378 2384
28. Borden EC Amato DA Rosenbaum C Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcoma J Clin Oncol 5 1987 840 850
29. Goldstein D Cheuvart B Trump DL Phase II trial of carboplatin in soft tissue sarcoma Am J Clin Oncol 13 1990 420 423
30. Jelic S Kovcin V Milanovic N Randomised study of high-dose epirubicin versus high-dose epirubicin-cisplatin chemotherapy for advanced soft tissue sarcoma Eur J Cancer 33 1997 220 225
31. Edmonson JH Ryan LM Blum RH Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas J Clin Oncol 11 1993 1269 1275
32. Baker LH Frank J Fine G Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advance soft tissue sarcomas: A randomized comparative trial. A phase III, Southwest Oncology Group study (7613) J Clin Oncol 5 1987 851 861
33. Schoenfeld DA Rosenbaum C Horton J A comparison of adriamycin versus vincristine and adriamycin and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced sarcoma Cancer 15 1982 2757 2762
34. Crawley CR Judson IR Verrill M A phase I/II study of a 72 hour continuous infusion of etoposide in advanced soft tissue sarcoma Sarcoma 1 1997 149 154
35. Keizer HJ Crowther D Nielsen OS EORTC group phase II study of oral etoposide for pretreated soft tissue sarcoma Sarcoma 1 1997 99 101
36. (abstr) Fidias P Demetri G Harmon DC Navelbine shows activity in previously treated sarcoma patients: Phase II results from MGH//Dana Farber/Partner's Cancer Care study Proc Am Soc Clin Oncol 17 1998 513a
37. Knowling M Bramwell V Eisenhauer E Phase II trial of 10-EDAM in advanced soft tissue sarcoma Ann Oncol 5 1994 766 768
38. (abstr) Wasserheit C Blum RH Ryan L Phase II trial of edatrexate in adult patients with metastatic soft tissue sarcomas: An ECOG phase II trial Proc Am Soc Clin Oncol 17 1998 513a
39. Bramwell VHC Eisenhauer EA Blackstein M Phase II study of topotecan (NSC 609 699) in patients with recurrent or metastatic soft tissue sarcoma Ann Oncol 8 1995 847 848
40. (abstr) Rankin C Budd GT Hutchins L SWOG 9518: Phase II trial of continuous infusion topotecan in patients (pts) with advanced soft tissue sarcomas Proc Am Soc Clin Oncol 17 1998 523a
41. Van Hoesel OGCM Verweij J Clavel M Phase II study with taxotere (RP56976) in advanced soft tissue sarcomas of the adult Ann Oncol 5 1994 539 542
42. Bramwell V Blackstein M Belanger K A phase II study of docetaxel in chemotherapy-naive patients with recurrent or metastatic adult soft tissue sarcoma Sarcoma 2 1998 29 33
43. (abstr) Verweij J Judson J Crowther D Randomized study comparing docetaxel (taxotere) (T) to doxorubicin (D) in previously untreated soft tissue sarcomas (STS) Proc Am Soc Clin Oncol 16 1997 496a
44. Patel SR Linke KA Burgess MA Phase II study of paclitaxel in patients with soft tissue sarcomas Sarcoma 1 1997 95 97
45. Casper ES Waltzman RJ Schwartz GK Phase II trial of paclitaxel in patients with soft-tissue sarcoma Cancer Invest 16 1998 442 446
46. Crawford SM Jerwood D An assessment of the relative importance of the components of CYVADIC in the treatment of soft-tissue sarcomas using regression meta analysis Med Inform 19 1994 311 321
47. Edmonson JH Ryan LM Blum RH Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas J Clin Oncol 11 1993 1269 1275
48. Santoro A Tursz T Mouridsen H Doxorubicin versus cyvadic versus doxorubicin plus ifosfamide in first line treatment of advanced soft tissue sarcomas: A randomized study of the EORTC Soft Tissue and Bone Sarcoma Group J Clin Oncol 13 1995 1531 1545
49. Antman K Crowley J Balcerzak SP An Intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas J Clin Oncol 11 1993 1276 1285
50. (abstr) Blay JY van Glabbeke M Nielsen OS Five-year survivors in patients with advanced soft tissue sarcoma (ASTS) treated with doxorubicin: A study on 1742 patients (STBSG) Proc Am Soc Clin Oncol 17 1998 512a
51. De Pas T De Braud F Orlando L High-ifosfamide plus adriamycin in the treatment of adult advanced soft tissue sarcomas: Is it feasible? Ann Oncol 9 1998 917 919
52. Leyvraz M Bacchi M Cerny T Phase I multicenter study of combined high-dose ifosfamide and doxorubicin in the treatment of advanced sarcomas Ann Oncol 9 1998 877 884
53. Frustaci S Buonadonna A Galligioni E Increasing 4-epidoxorubicin and fixed ifosfamide doses plus granulocytemacrophage colony-stimulating factor in advanced soft tissue sarcomas: A pilot study J Clin Oncol 15 1997 1418 1426
54. Reichardt P Tilgner J Hohenberger P Dose-intensive chemotherapy with ifosfamide, epirubicin, and filgrastim for adult patients with metastatic or locally advanced soft tissue sarcoma: A phase II study J Clin Oncol 16 1998 1438 1443
55. (abstr) Vadhan-Raj S Patel S Burgess M Phase II trial of adriamycin (A), ifosfamide (I), mesna (M) uroprotection, cadarbazine (D) (MAID) with pixy321 (GM-CSF/IL-3 fusion protein) or G-CSF in patients (pts) with soft tissue sarcoma (STS) Proc Am Soc Clin Oncol 15 1996 525
56. (abstr) Bui NB Demaille MC Chevreasu C qMAID vs MAID+25% with G-CSF in adults with advanced soft tissue sarcoma (STS): First results of a randomized study of the FNCLCC sarcoma group Proc Am Soc Clin Oncol 17 1998 517a
57. Reichardt P Verweij J Crowther D Should high-dose chemotherapy be used in the treatment of soft tissue sarcoma Eur J Cancer 33 1997 1351 1360
58. (abstr) Kessinger A Armitage JO High dose therapy with autologous bone marrow transplantation for advanced soft tissue sarcoma Proc Am Soc Clin Oncol 6 1987 126
59. Dumontet C Biron P Boufett E High dose chemotherapy with ABMT in soft tissue sarcomas: A report of 22 cases Bone Marrow Transplant 10 1992 405 408
60. Ghalie R Reynolds J Valentino LA Busulfan-containing pre-transplant regimens for the treatment of solid tumors Bone Marrow Transplant 14 1994 437 442
61. (abstr) Myong H Rosen G Forscher C High dose chemotherapy (CTX) with autologous peripheral stem cell transplantation (PSCT) for advance sarcoma Proc Am Soc Clin Oncol 17 1998 511a
62. Pinkerton CR Megatherapy for soft tissue sarcoma: EBMT experience Bone Marrow Transplant 7 1991 120 122
63. Sugarbaker PH Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis Semin Surg Oncol 14 1998 245 261
64. (abstr) Alberts DS Liu PY Hannigan EV Phase III study of intraperitoneal cisplatin/IV cyclophosphamide vs. IV cisplatin/IV cyclophosphamide in patients with optimal disease stage III ovarian cancer: A SWOG-GOG-ECOG Intergroup study Proc Am Soc Clin Oncol 14 1995 273
65. Markman M Intraperitoneal chemotherapy in the treatment of ovarian cancer Ann Med 28 1996 293 296
66. Bonvalot S Lecesne A Perrier P Preliminary evaluation of complete resection of major sarcomatosis followed by randomization of early post-operative intraperitoneal chemotherapy Sarcoma 1 1997 202
67. Stephens AD Belliveau JF Sugarbacker PH Intraoperative hyperthermic lavage with cisplatin for peritoneal carcinomatosis and sarcomatosis Sugarbaker PH Peritoneal Carcinomatosis: Drugs and Diseases. Cancer Treatment and Research 1996 Kluwer Academic Publishers Boston, MA 15 30
68. Eilber FC Eilber FR Rosen G Surgical resection and adjuvant intraperitoneal chemotherapy for recurrent abdominal sarcomas Sarcoma 1 1997 197 198
69. Frost DB Pulmonary metastasectomy for soft tissue sarcomas: Is it justified? J Surg Oncol 59 1995 110 115
70. van Geel AN Pastorino U Jauch KW Surgical treatment of lung metastases: The EORTC Soft Tissue and Bone Sarcoma Group study of 255 patients Cancer 77 1996 675 682
71. Harrison LE Brennan MF Newman E Hepatic resection for noncolorectal, nonneuroendocrine metastases: A fifteen-year experience with 96 patients Surgery 121 1997 625 632
72. Elias D Cavalcanti de Albuquerque A Eggenspieler P Resection of liver metastases from a noncolorectal primary: Indications and results based on 147 monocentric patients J Am Coll Surg 187 1998 487 493
73. Wiklund T Saeter G Strander H The outcome of advanced soft tissue sarcoma patients with complete tumor regression after either chemotherapy alone or chemotherapy plus surgery. The Scandinavian Sarcoma Group Experience Eur J Cancer 33 1997 357 361